Matches in Wikidata for { <http://www.wikidata.org/entity/Q92366376> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q92366376 description "article scientifique publié en 2019" @default.
- Q92366376 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92366376 description "im August 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92366376 description "scientific article published on 02 August 2019" @default.
- Q92366376 description "wetenschappelijk artikel" @default.
- Q92366376 description "наукова стаття, опублікована 2 серпня 2019" @default.
- Q92366376 name "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials" @default.
- Q92366376 name "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials" @default.
- Q92366376 type Item @default.
- Q92366376 label "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials" @default.
- Q92366376 label "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials" @default.
- Q92366376 prefLabel "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials" @default.
- Q92366376 prefLabel "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials" @default.
- Q92366376 P1433 Q92366376-A9B856B8-9A52-45D3-BD29-2F88B19211D2 @default.
- Q92366376 P1476 Q92366376-F336248B-C5FA-4C47-8E7B-16741B348A8C @default.
- Q92366376 P2093 Q92366376-081DAE3C-C8FD-4752-AFA6-3F392D7007BA @default.
- Q92366376 P2093 Q92366376-30D9B3A3-AA2E-44AC-83D0-19CFEF7489AB @default.
- Q92366376 P2093 Q92366376-343332CA-9919-48FF-95BF-F63E8CA48555 @default.
- Q92366376 P2093 Q92366376-371D6DE2-2742-45D3-AF4C-F4BE4FA7F202 @default.
- Q92366376 P2093 Q92366376-3A632889-C1DE-4555-B4F5-CCA90DAA892F @default.
- Q92366376 P2093 Q92366376-7992153F-1830-45C3-982A-EF085610F710 @default.
- Q92366376 P2093 Q92366376-8D4F77A7-F626-4280-87E4-EF0B66693AB6 @default.
- Q92366376 P2093 Q92366376-8EB25611-BC30-4733-A449-B99FC209DE88 @default.
- Q92366376 P2093 Q92366376-B06AF523-6817-4912-AD83-66EBCCA89640 @default.
- Q92366376 P2093 Q92366376-B5D482CF-4996-44C8-B3EB-C16E6DAD9249 @default.
- Q92366376 P2093 Q92366376-D97EF27E-D791-4E46-B7D7-4D8EE8962C6F @default.
- Q92366376 P2093 Q92366376-F1CE37F6-8D2D-4486-A48D-94FCA7EBC035 @default.
- Q92366376 P304 Q92366376-91BA0773-F79E-4F43-A29E-547379F8736A @default.
- Q92366376 P31 Q92366376-54D171CC-78F6-449C-8F7F-9DDFC012E68C @default.
- Q92366376 P356 Q92366376-846CEE20-9B7E-43BB-BD3C-7335B35D45F3 @default.
- Q92366376 P433 Q92366376-9D7848E9-EA58-4B02-877B-8846B9FF8C12 @default.
- Q92366376 P478 Q92366376-5C90C695-6715-43DF-9399-0F5486E7C672 @default.
- Q92366376 P577 Q92366376-C213B25A-303B-47FB-934D-1AD72A86020A @default.
- Q92366376 P698 Q92366376-690FE9FF-6951-4A5D-AD83-ADC46DA34730 @default.
- Q92366376 P921 Q92366376-8308EBFF-B65E-408E-8084-1C55D8875A9D @default.
- Q92366376 P921 Q92366376-F8A841D2-D37C-4AAE-AB8A-B5C61F5616C8 @default.
- Q92366376 P356 JOP.2018.0154 @default.
- Q92366376 P698 31373837 @default.
- Q92366376 P1433 Q15755845 @default.
- Q92366376 P1476 "Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b/3 and 3 Clinical Trials" @default.
- Q92366376 P2093 "Abayomi Ogundele" @default.
- Q92366376 P2093 "April Jasper" @default.
- Q92366376 P2093 "Barry A Schechter" @default.
- Q92366376 P2093 "Bridgitte Shen Lee" @default.
- Q92366376 P2093 "Charles H Darby" @default.
- Q92366376 P2093 "Douglas K Devries" @default.
- Q92366376 P2093 "George Varghese" @default.
- Q92366376 P2093 "Jodi Luchs" @default.
- Q92366376 P2093 "Josh Johnston" @default.
- Q92366376 P2093 "Paul Karpecki" @default.
- Q92366376 P2093 "Robert Smyth-Medina" @default.
- Q92366376 P2093 "Shane R Kannarr" @default.
- Q92366376 P304 "388-394" @default.
- Q92366376 P31 Q13442814 @default.
- Q92366376 P356 "10.1089/JOP.2018.0154" @default.
- Q92366376 P433 "7" @default.
- Q92366376 P478 "35" @default.
- Q92366376 P577 "2019-08-02T00:00:00Z" @default.
- Q92366376 P698 "31373837" @default.
- Q92366376 P921 Q1162694 @default.
- Q92366376 P921 Q367700 @default.